TY - JOUR
T1 - Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease
AU - Cantero, Jose L.
AU - Atienza, Mercedes
AU - Sanchez-Juan, Pascual
AU - Rodriguez-Rodriguez, Eloy
AU - Vazquez-Higuera, Jose Luis
AU - Pozueta, Ana
AU - Gonzalez-Suarez, Andrea
AU - Vilaplana, Eduard
AU - Pegueroles, Jordi
AU - Montal, Victor
AU - Blesa, Rafael
AU - Alcolea, Daniel
AU - Lleo, Alberto
AU - Fortea, Juan
PY - 2018/4/1
Y1 - 2018/4/1
N2 - © 2017 Elsevier Inc. The diagnostic value of cerebrospinal fluid (CSF) biomarkers is well established in Alzheimer's disease, but our current knowledge about how abnormal CSF levels affect cerebral integrity, at local and network levels, is incomplete in asymptomatic older adults. Here, we have collected CSF samples and performed structural magnetic resonance imaging scans in cognitively normal elderly as part of a cross-sectional multicenter study (SIGNAL project). To identify group differences in cortical thickness, white matter volume, and properties of structural networks, participants were split into controls (N = 20), positive amyloid-β (Aβ 1–42+ ) (N = 19), and positive phosphorylated tau (N = 18). The Aβ 1–42+ group exhibited thickening of middle temporal regions, while positive phosphorylated tau individuals showed thinning in the superior parietal and orbitofrontal cortices. Subjects with abnormal CSF biomarkers further showed regional white matter atrophy and more segregated cortical networks, the Aβ 1–42+ group showing heightened isolation of cingulate and temporal cortices. Collectively, these findings highlight the relevance of combining structural brain imaging and connectomics for in vivo tracking of Alzheimer's disease lesions in asymptomatic stages.
AB - © 2017 Elsevier Inc. The diagnostic value of cerebrospinal fluid (CSF) biomarkers is well established in Alzheimer's disease, but our current knowledge about how abnormal CSF levels affect cerebral integrity, at local and network levels, is incomplete in asymptomatic older adults. Here, we have collected CSF samples and performed structural magnetic resonance imaging scans in cognitively normal elderly as part of a cross-sectional multicenter study (SIGNAL project). To identify group differences in cortical thickness, white matter volume, and properties of structural networks, participants were split into controls (N = 20), positive amyloid-β (Aβ 1–42+ ) (N = 19), and positive phosphorylated tau (N = 18). The Aβ 1–42+ group exhibited thickening of middle temporal regions, while positive phosphorylated tau individuals showed thinning in the superior parietal and orbitofrontal cortices. Subjects with abnormal CSF biomarkers further showed regional white matter atrophy and more segregated cortical networks, the Aβ 1–42+ group showing heightened isolation of cingulate and temporal cortices. Collectively, these findings highlight the relevance of combining structural brain imaging and connectomics for in vivo tracking of Alzheimer's disease lesions in asymptomatic stages.
KW - CSF biomarkers
KW - Cortical thickness
KW - Preclinical Alzheimer's disease
KW - SNAP
KW - Structural cortical networks
KW - White matter
U2 - 10.1016/j.neurobiolaging.2017.12.010
DO - 10.1016/j.neurobiolaging.2017.12.010
M3 - Article
SN - 0197-4580
VL - 64
SP - 58
EP - 67
JO - Neurobiology of Aging
JF - Neurobiology of Aging
ER -